Dr. Vickery, an Atlanta native, is a pediatric allergist-immunologist. He serves as Director of the Food Allergy Program and Associate Professor of Emory University School of Medicine.
Prior to joining Children’s Healthcare of Atlanta, Dr. Vickery held faculty positions at Duke University School of Medicine and the University of North Carolina-Chapel Hill School of Medicine. While working at the University of North Carolina School of Medicine, he led a group that was first to show sustained unresponsiveness can occur after peanut OIT. He subsequently demonstrated that early treatment of peanut-allergic preschool children with OIT is safe and leads to better outcomes. Most recently at UNC, Dr. Vickery led the development of an investigational treatment for peanut allergy as a Senior Medical Director at Aimmune Therapeutics.
Dr. Vickery has published more than 50 papers in leading journals and has presented his work at national and international meetings. He has also contributed to the development of national food allergy treatment guidelines. Dr. Vickery has received several awards for clinical care as well as research awards from the American Academy of Allergy, Asthma and Immunology (AAAAI), the American College of Allergy, Asthma and Immunology, and the British Society of Allergy and Clinical Immunology.
Focus of Practice
Areas of Interest
- Atopic dermatitis
- Eosinophilic disease
- Food allergies
- General pediatric allergy and immunology
Research & Publications
Dr. Vickery’s research efforts focus on understanding the pathophysiology of food allergies and anaphylaxis as well as developing new therapies to treat them.
In the News
A new study found that gradually exposing children to peanut protein could increase their tolerance.
Study results suggest that treatment can protect some children against accidental exposure to or ingestion of a very small amount of peanuts or peanut products.
Results from a new study may lead to approval of what could be the first drug that ameliorates potentially deadly reactions in children with severe peanut allergies.
New York Times